Arvinas (ARVN) Other Non-Current Assets (2017 - 2026)

Arvinas' (ARVN) quarterly Other Non-Current Assets came in at $3.5 million in Q1 2026, down 27.08% year-on-year from $4.8 million in Q1 2025, and down 7.89% quarter-over-quarter from $3.8 million in Q4 2025.

Arvinas (ARVN) Other Non-Current Assets (2017 - 2026) Analysis & Trends

Arvinas' Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $3.5 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets fell 27.08% year-over-year to $3.5 million in Q1 2026; TTM through Mar 2026 was $3.5 million, a 27.08% decrease from a year earlier, with the FY2025 full-year figure at $3.8 million, down 53.09% from the prior year.
  • Other Non-Current Assets fell to $3.5 million in Q1 2026 per ARVN's latest filing, from $3.8 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $12.1 million in Q1 2022 and bottomed at $3.5 million in Q1 2026.
  • The 5-year median for Other Non-Current Assets is $9.9 million (2024), against an average of $8.6 million.
  • Across the five-year window, Other Non-Current Assets climbed 14.85% in 2024 and slumped 62.07% in 2025, its largest moves.
  • Year by year, Other Non-Current Assets stood at $10.8 million in 2022, then fell by 3.7% to $10.4 million in 2023, then slipped by 22.12% to $8.1 million in 2024, then plunged by 53.09% to $3.8 million in 2025, then dropped by 7.89% to $3.5 million in 2026.
  • Per Business Quant, the three latest ARVN Other Non-Current Assets figures stand at $3.5 million (Q1 2026), $3.8 million (Q4 2025), and $3.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 1.02 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 60,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 104.24 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 289.41 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 14.48 Mn
10 Arvinas 512.64 Mn -102.26 Mn - 3.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.50 Mn
Dec 31, 2025 3.80 Mn
Sep 30, 2025 3.90 Mn
Jun 30, 2025 4.40 Mn
Mar 31, 2025 4.80 Mn
Dec 31, 2024 8.10 Mn
Sep 30, 2024 9.80 Mn
Jun 30, 2024 11.60 Mn
Mar 31, 2024 9.90 Mn
Dec 31, 2023 10.40 Mn
Sep 30, 2023 9.60 Mn
Jun 30, 2023 10.10 Mn
Mar 31, 2023 10.30 Mn
Dec 31, 2022 10.80 Mn
Sep 30, 2022 11.30 Mn
Jun 30, 2022 11.70 Mn
Mar 31, 2022 12.10 Mn
Dec 31, 2021 12.50 Mn
Sep 30, 2021 12.84 Mn
Sep 30, 2020 28,777.00